Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 8 Prostatic Neoplasms 7 Leukemia, Myeloid, Acute 6 Colorectal Neoplasms 5 Breast Neoplasms 5 Stomach Neoplasms 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Congenital Abnormalities 4 Pancreatic Neoplasms 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lung Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Venous Thromboembolism 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Papillomavirus Infections 2 Neuroblastoma 2 Neoplasm Metastasis 2 Motor Activity 2 Melanoma 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2

Interventions

testosterone undecanoate 3 Alendronate 2 Triptorelin Pamoate 1 Testosterone 1 Orchiectomy 1 Observation 1 Gonadotropin-Releasing Hormone 1 Clomiphene 1 Castor Oil 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hypogonadism × Observation × Clear all

NCT02471157 2019-01-25

HPOS

Weill Medical College of Cornell University

Hypogonadism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡